国产日韩欧美不卡高清小视频,激情亚洲内射一区二区三区,日日摸夜夜添夜夜添国产95,欧美在线观看一区二区三区免费,亚洲乱码av一区二区三区女同,亚洲女久久久噜噜噜综合,亚洲av日韩av高清在线观看,中文字幕一区二区va在线

CD38分子(CD38)活性蛋白

Active Cluster Of Differentiation 38 (CD38)

cADPRH; ADPRC 1; c-ADPRH; T10; p45; 2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase; ADP-ribosyl cyclase 1

  • CD38分子(CD38)活性蛋白 產(chǎn)品包裝(模擬)
  • CD38分子(CD38)活性蛋白 產(chǎn)品包裝(模擬)
  • APA752Hu61.jpg Figure. SDS-PAGE
  • Certificate 通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證

活性實驗

Cyclic ADP Ribose Hydrolase (cADPRH), commonly known as CD38, is a multifunctional enzyme widely expressed on various cell surfaces. Its primary function involves catalyzing the synthesis and hydrolysis of cyclic ADP-ribose (cADPR) from NAD?. cADPR is a crucial secondary messenger that mobilizes calcium ions from intracellular stores, thereby playing a vital role in regulating calcium signaling. This process is essential for numerous physiological functions, including immune response, insulin secretion, and neural signaling. CD38's involvement in calcium homeostasis links it to metabolic diseases, aging, and immune disorders. Furthermore, it serves as a cell surface marker in hematological malignancies and is a target for therapeutic antibodies.Besides,CD19 has been identified as an interactor of cADPRH, thus a functional binding ELISA assay was conducted to detect the interaction of recombinant human cADPRH and recombinant human CD19. Briefly, biotin-linked cADPRH were diluted serially in PBS, with 0.01% BSA (pH 7.4). Duplicate samples of 100μl were then transferred to CD19-coated microtiter wells and incubated for 1h at 37℃. Wells were washed with PBST 3 times and incubation with Streptavidin-HRP for 30min, then wells were aspirated and washed 5 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50μl stop solution to the wells and read at 450nm immediately. The binding activity of cADPRH and CD19 was shown in Figure 1, the EC50?for this effect is 0.25497μg/mL.

用法

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

儲存

避免反復(fù)凍融。2-8°C不超過一個月,-80°C不超過12個月。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲,損失率低于5%。

相關(guān)產(chǎn)品

編號 適用物種:Homo sapiens (Human,人) 應(yīng)用(僅供研究使用,不用于臨床診斷!)
UEPA752Hu61 CD38分子(CD38)真核蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
UAPA752Hu61 CD38分子(CD38)活性蛋白 Cell?culture;?Activity?Assays.
URPA752Hu01 CD38分子(CD38)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
UPAA752Hu01 CD38分子(CD38)多克隆抗體 IHC; ICC/IF
UMAA752Hu21 CD38分子(CD38)單克隆抗體 WB; IHC; ICC; IP.
UMAA752Hu22 CD38分子(CD38)單克隆抗體 WB; IHC; ICC; IP.
URAA752Hu21 CD38分子(CD38)重組抗體 ICC/IF; FCM
UMAA752Hu23 CD38分子(CD38)單克隆抗體 WB; IHC
UMAA752Hu24 CD38分子(CD38)單克隆抗體 WB; IHC
UMAA752Hu25 CD38分子(CD38)單克隆抗體 WB; IHC
UFAA752Hu02 抗CD38分子(CD38)單克隆抗體 FCM
UFAA752Hu04 抗CD38分子(CD38)單克隆抗體 FCM
UFAA752Hu08 抗CD38分子(CD38)單克隆抗體 FCM
UFAA752Hu06 抗CD38分子(CD38)單克隆抗體 FCM
UFAA752Hu82 抗CD38分子(CD38)單克隆抗體(異硫氰酸熒光素標(biāo)記) FCM
USEA752Hu CD38分子(CD38)檢測試劑盒(酶聯(lián)免疫吸附試驗法) Enzyme-linked immunosorbent assay for Antigen Detection.
ULMA752Hu CD38分子(CD38)等多因子檢測試劑盒(流式熒光發(fā)光法) FLIA Kit for Antigen Detection.

參考文獻(xiàn)

雜志 參考文獻(xiàn)
Neurological Research Increased hippocampal CD38 and systemic inflammation after partial hepatectomy does not indu [pubmed:27724820]
留言咨詢
巴塘县| 正定县| 宁化县| 永春县| 梅州市| 广西| 太谷县| 和林格尔县| 巨野县| 乳山市| 民县| 龙游县| 靖远县| 法库县| 孝义市| 永新县| 和林格尔县| 灵台县| 沁阳市| 平泉县| 南木林县| 常德市| 尚志市| 台中县| 息烽县| 招远市| 通州区| 恩平市| 阿拉善盟| 诸城市| 黄浦区| 延安市| 蒙阴县| 教育| 乐陵市| 玉门市| 塘沽区| 新安县| 若羌县| 抚州市| 广饶县|